Jackson; David Y.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Jackson; David Y..The latest application filed is for "immunoconjugates targeting her2".
Company Profile
7.13.32
- Jackson; David Y. - Redwood City CA
- Jackson; David Y. - Belmont CA
- Jackson; David Y. - San Bruno CA
- Jackson; David Y. - San Mateo CA
Patent Activity
| Patent | Date |
|---|---|
| Immunoconjugates targeting HER2 Grant 11,400,164 - Ackerman , et al. August 2, 2 | 2022-08-02 |
| Linkers for antibody-drug conjugates and related compounds, compositions, and methods of use Grant 11,229,711 - Jackson , et al. January 25, 2 | 2022-01-25 |
| Immunoconjugates Targeting HER2 App 20220001022 - Ackerman; Shelley Erin ; et al. | 2022-01-06 |
| Immunoconjugate Synthesis Method App 20210284750 - Jackson; David Y. ; et al. | 2021-09-16 |
| Antibody adjuvant conjugates Grant 11,110,178 - Alonso , et al. September 7, 2 | 2021-09-07 |
| Immunoconjugates Targeting EGFR App 20210187115 - Alonso; Michael N. ; et al. | 2021-06-24 |
| Immunoconjugates App 20210154316 - Alonso; Michael N. ; et al. | 2021-05-27 |
| Modified Antibodies And Related Compounds, Compositions And Methods Of Use App 20210139596 - Jackson; David Y. ; et al. | 2021-05-13 |
| Antibody-drug Conjugates And Related Compounds, Compositions And Methods App 20200392108 - Jackson; David Y. ; et al. | 2020-12-17 |
| Antibody Adjuvant Conjugates App 20200206357 - Alonso; Michael Nathaniel ; et al. | 2020-07-02 |
| Antibody adjuvant conjugates Grant 10,675,358 - Alonso , et al. | 2020-06-09 |
| Antibody Adjuvant Conjugates App 20200108151 - Jackson; David Y. ; et al. | 2020-04-09 |
| Novel Antibody-drug Conjugates And Related Compounds, Compositions And Methods Of Use App 20190209704 - JACKSON; David Y. ; et al. | 2019-07-11 |
| Antibody Adjuvant Conjugates App 20190076547 - Alonso; Michael Nathaniel ; et al. | 2019-03-14 |
| Antibody Adjuvant Conjugates App 20190015516 - Jackson; David Y. ; et al. | 2019-01-17 |
| Antibody-drug Conjugates, Compositions And Methods Of Use App 20180147294 - JACKSON; David Y. ; et al. | 2018-05-31 |
| Antibody-Drug Conjugates and Related Compounds, Compositions, and Methods App 20160303247 - Jackson; David Y. ; et al. | 2016-10-20 |
| Antibody-Drug Conjugates, Compositions and Methods of Use App 20140363454 - Jackson; David Y. ; et al. | 2014-12-11 |
| Antibody-Drug Conjugates and Related Compounds, Compositions, and Methods App 20130224228 - Jackson; David Y. ; et al. | 2013-08-29 |
| Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use Grant 7,947,839 - Gazzard , et al. May 24, 2 | 2011-05-24 |
| Tyrosine Derivative App 20090325962 - Jackson; David Y. ; et al. | 2009-12-31 |
| Tyrosine derivatives Grant 7,595,399 - Jackson , et al. September 29, 2 | 2009-09-29 |
| Macrocyclic Depsipeptide Antibody-drug Conjugates And Methods App 20090226465 - Jackson; David Y. | 2009-09-10 |
| Integrin receptor inhibitors Grant 7,265,146 - Artis , et al. September 4, 2 | 2007-09-04 |
| Antibody drug conjugates and methods App 20070134243 - Gazzard; Lewis J. ; et al. | 2007-06-14 |
| Thiocarbamate inhibitors of alpha-4 integrins Grant 7,166,600 - Jackson January 23, 2 | 2007-01-23 |
| Assay method App 20060234306 - Artis; Dean R. ; et al. | 2006-10-19 |
| Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use App 20060182751 - Gazzard; Lewis J. ; et al. | 2006-08-17 |
| Thiocarbamate inhibitors of alpha-4 integrins App 20060122388 - Jackson; David Y. | 2006-06-08 |
| Thiocarbamate inhibitors of alpha-4 integrins Grant 7,015,323 - Jackson March 21, 2 | 2006-03-21 |
| Assay method App 20050233387 - Artis, Dean R. ; et al. | 2005-10-20 |
| Integrin receptor inhibitors App 20050187284 - Artis, Dean R. ; et al. | 2005-08-25 |
| Integrin receptor inhibitors Grant 6,933,314 - Artis , et al. August 23, 2 | 2005-08-23 |
| Thiocarbamate inhibitors of alpha-4 integrins App 20040235750 - Jackson, David Y. | 2004-11-25 |
| Tyrosine derivatives App 20040158076 - Jackson, David Y. ; et al. | 2004-08-12 |
| Tyrosine derivatives App 20040110753 - Jackson, David Y. ; et al. | 2004-06-10 |
| Integrin receptor inhibitors App 20040077693 - Artis, Dean R. ; et al. | 2004-04-22 |
| Integrin receptor inhibitors Grant 6,706,753 - Artis , et al. March 16, 2 | 2004-03-16 |
| Assay method App 20030129675 - Artis, Dean R. ; et al. | 2003-07-10 |
| Integrin receptor inhibitors App 20030100599 - Artis, Dean R. ; et al. | 2003-05-29 |
| Tyrosine derivatives Grant 6,469,047 - Jackson , et al. October 22, 2 | 2002-10-22 |
| Integrin receptor inhibitors App 20020035104 - Artis, Dean R. ; et al. | 2002-03-21 |
| Assay method App 20020004247 - Artis, Dean R. ; et al. | 2002-01-10 |
| Methods of use of serine protease variants having peptide ligase activity Grant 5,629,173 - Abrahmsen , et al. May 13, 1 | 1997-05-13 |
Company Registrations
| NCAGE Code | 8FYJ6 | JACKSON, DAVID Y |
| CAGE Code | 8FYJ6 | JACKSON, DAVID Y DYJ PHARMA |
| S.A.M. Registration | 8FYJ6 [117352431] | JACKSON, DAVID Y |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 